Biomarker Technologies Market Players, Industry Trends, Segments, Analysis and Forecast – 2030

Biomarker Technologies Market

The Biomarker Technologies Market is projected to reach USD 68,232.60 Million by 2030 at 9.20% CAGR during the forecast period 2022-2030.

The term biomarker is usually used to define a measurable indicator of some biological state or condition. It is also referred to a substance whose detection indicates the presence of a living organism. Biomarkers are used for diagnosis and clinical decision making in cancer, diabetes, and cardiovascular and neurological diseases. The market for biomarker technologies is growing worldwide due to drivers such as increased occurrence of above diseases, advances in the area of medical technologies, governmental initiatives supporting research in the area of biomarker technologies, and increasing uses of biomarkers to increase the accuracy of disease diagnosis. However, high capital investments required for the discovery, development of biomarkers, and the high cost of biomarkers are restraining the growth of the biomarker technologies market.

Major Key Players:

Market Research Future (MRFR) recognizes the following companies as Biomarker Technologies Market Players are Abbott Laboratories, Agilent Technologies (U.S.), Thermo Fisher Scientific (U.S.), Roche (Switzerland), Waters Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthcare, and Bio-Rad Laboratories (U.S.).     

Segment Analysis

The global biomarker technology market is segmented on the basis of product type, profiling technology, disease application, and research areas. Considering product type, the market is segmented into consumables, instruments, services, and software/informatics.

By profiling technology, the market is segmented into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. Based on immunoassay, the market is again segmented into ELISA, western blot, and protein microarray.

With reference to disease application, the market is segmented into cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

On account of research areas, the market is segmented into genomic biomarkers, Proteomics, Metabolomics, and other research areas. Metabolomics is further segmented into lipidomic and others.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Regional Analysis

Americas has the largest market share in the biomarker technologies market. The increasing prevalence of cancer, cardiovascular diseases, neurological as well as autoimmune diseases, and rising geriatric population are likely to enhance the growth of the biomarker technologies market.  For instance, the National Cancer Institute (NCI) had stated that 1,666,540 new cases of cancer were reported during 2014 in the United States. Thus, this increasing patient pool will enhance the market growth during the forecast period. Additionally, factors such as increasing government initiatives and funding for research and development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of the biomarker technologies market in the American region. Furthermore, according to CMS (Centers for Medicare and Medicaid Services) the U.S. health care spending increased by 4.3 percent to reach USD 3.3 trillion per person in 2016. Thus, increasing per capita income of individuals as well as rising healthcare spending will aid up the market growth in Americas.

Europe is the second largest market leader and holds a healthy share in the global biomarker technologies market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities and established healthcare infrastructure, along with the growing need for efficient and accurate diagnosis. Furthermore, according to the Cancer Research U.K., there were around 9, 921 cases of cancer diagnosed in 2015. The increasing occurrence of cancer is expected to have a positive impact on the biomarker technologies market due to its wide usage in cancer. This impact will enhance the biomarker technologies market in Europe.

Asia Pacific is expected to be the fastest emerging market. Factors such as the increasing prevalence of chronic diseases are the major driver for the market growth. For instance, in accordance with the International Diabetes Federation, nearly 382 million people had diabetes in 2013 worldwide. This is expected to reach around 500 million by the end of 2035. China and India are the first and second most affected countries with diabetes. This rising number of diabetic patients can lead to the increasing patient number with cardiovascular diseases. So, these countries are expected to be the fastest growing regions due to the increasing patient pool, raising awareness about health, and availability of new treatment methods.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Angiography Equipment Market Overview, Growth Opportunities and Forecast to 2030

Angiography Equipment Market

The angiography equipment market is growing rapidly attributing to the increasing number of cases of cardiovascular and coronary diseases, which are the result of changing lifestyle. Over the last three decades, equipment used in angiography procedures have evolved significantly demonstrating remarkable advances. Such betterments are predominantly driving the growth of the market. Also, there has been a remarkable growth in the awareness about coronary diseases and cardiovascular-related surgeries, which is escalating the market on the global platform.

The Angiography Equipment Market is projected to reach USD 12.45 Billion by 2030 at 5.20% CAGR during the forecast period 2022-2030. Technological advancements in interventional radiology is a key driving force behind the growth of the market.

Additional factors acting as significant growth propellers to the market include the rising prevalence of cardiovascular diseases, increasing numbers of angiography procedures, and benefits of the technique in early diagnosis & treatments. Also, the growing demand for interventional angiography systems in minimally invasive surgeries and rising healthcare expenditures are defining the growing landscape of the market.

On the other hand, limitations in reimbursement for angiographic surgeries and risk of radiation exposure are major growth restraining factors of the market. Nevertheless, factors, such as the improving economic conditions that are increasingly expanding the access to the quality healthcare would support the growth of the angiography equipment market over the assessment period, increasing per-capita healthcare expenses.

Major Key Players:

Players leading the global Angiography Equipment Market Players include Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Boston Scientific Corporation (US), Canon Corporation (Japan), Cordis, a Cardinal Health Company, (US), Medtronic (Ireland), Shimadzu Corporation (Japan), Angiodynamics (US), Abbott Laboratories (US), B. Braun Melsungen (Germany), and Terumo (Japan), among others.

Segment Analysis

The report is segmented into seven key market dynamics to widen the scope of understanding,

By Product: Angiography Catheters, Angiography Systems, Angiography Contrast Media, Angiography Balloons, Vascular Closure Devices (VCDs), Angiography Guidewires, and Angiography Accessories, fluorescein angiography machine.

By Technology:  CT angiography, X-ray angiography, MR angiography, and other angiography technologies.

By Procedure:Endovascular Angiography, Coronary Angiography, Neuro-Angiography, Onco-Angiography, and other Angiography Procedures.

By Indication: Valvular Heart Disease, Coronary Artery Disease, Congenital Heart Disease, Congestive Heart Failure, and other indications.

By Application: Diagnostics and Therapeutics.

By End-user: Hospitals & Clinics, Diagnostic & Imaging Centers, and Research Institutes.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.

Regional Analysis

Europe is considered as the leading region in the global angiography equipment market. Factors, such as the high per capita healthcare expenditures and the growing population act as major tailwinds to the regional market growth. Moreover, a well-developed infrastructure, increasing prevalence of cardiovascular disorders, spreading awareness of CABG procedures, and technological advancements are expected to spur the market growth in the region.

Additionally, increasing numbers of angiography procedures and growing preference of minimally invasive devices contribute to the growth of the regional market. Furthermore, the resurging economy is playing a vital role in increasing the value of the regional market, increasing access to quality care. Also, the availability of specialty care services in hospitals & tertiary care centers, increasing demand for the treatment options of cardiovascular diseases, and rising prevalence of cardiovascular diseases escalate the market growth in the region.

Moreover, factors positively impacting the growth of the regional market include the growing emphasis on coronary artery bypass procedures and increasing geriatric population with chronic diseases such as diabetes & obesity which increase the risk for heart disease and cardiovascular diseases.

North America accounts for the second-largest market for angiography equipment, globally. The region witnesses an increasing number of coronary artery bypass procedures. In addition, the increasing expenditure on healthcare and the well-developed healthcare sector are positively impacting the growth of the market. Besides, the presence of state-of-the-art-infrastructure that allows the development of technologies and early adoption of advanced technologies contribute to the growth of the market in this region.

Moreover, high per capita healthcare spending and the growing prevalence of coronary diseases in the region are expected to spur the market growth in the region. Markets in the US and Canada led by the rising number of bypass surgeries lead the regional market. Furthermore, the rapid uptake of advanced technologies and devices in the surgical process is also an essential growth driver of the market.

The Asia Pacific angiography equipment market is emerging as a promising market globally. The region is heading with the rising cases of patients suffering from cardiovascular disease and coronary diseases. Factors, such as the huge growth in the healthcare sector in highly populated countries like India, Japan, and China, can drive regional market growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Myasthenia Gravis Disease Market Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2030

Myasthenia Gravis Disease Market

The surging cases of neuromuscular disorders are estimated to favor the market growth globally. Myasthenia gravis is referred to as a neuromuscular disorder which results in the skeletal muscles to weaken.

The Myasthenia Gravis Disease Market is projected to reach USD 1.9 Billion by 2030 at 7.70% CAGR during the forecast period 2022-2030.

The disease generally occurs due to the impairment of communication between the nerve cells and the muscles and causes difficulty in the relaxation and contraction of muscles. The antibodies present in the body destroy the receptor for acetylcholine at the neuromuscular joint which prevents the muscles from contracting and performing its normal function.

Major Key Players:

Leading Myasthenia Gravis Disease Market Players are Fresenius Kabi, GSK plc, AbbVie Inc., Biogen Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., Cipla, RPG Life Sciences, Teva Pharmaceutical Industries Ltd., Apotex Corporation, Novartis, Piramal Healthcare, Sun Pharmaceuticals Industries Ltd., and Valeant.

Segment Analysis

The global myasthenia gravis market has been segmented on the basis of diagnosis, treatment, and end-user.

On the basis of diagnosis, the global myasthenia gravis disease market can be segmented into imaging, blood tests, electrodiagnostic, edrophonium tests, pulmonary function tests, and others. The imaging segment is classified into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others.

On the basis of treatment, the global myasthenia gravis disease market can be segmented into medication, surgery, autologous hematopoietic stem cell transplantation (HSCT), plasmapheresis and intravenous immunoglobulin, and others. By medication, the market is divided into acetylcholinesterase inhibitors, immunosuppressants, steroids, and others. The acetylcholinesterase inhibitors segment is further classified into atropine, neostigmine, pyridostigmine, and others. Immunosuppressant drugs are further divided into azathioprine, mycophenolate mofetil, tacrolimus, and rituximab. The steroids segment is further divided into prednisone and others. Surgery is divided into thymectomy and others.

On the basis of end user, the global myasthenia gravis disease market is segmented into hospitals, clinics, academic research institutes, and others.

Regional Analysis

The global myasthenia gravis disease market is expected to be dominated by North America over the forecast period, with the Americas segment holding the dominant share in the market. The Americas market for myasthenia gravis disease is mainly driven by the growing awareness about the disease, as neurological diseases have been studied in detail in the region and awareness about this kind of disease is significantly high in the region. The growing demand for effective medications for neuromuscular diseases such as myasthenia gravis is likely to drive the drug development scenario in the Americas region over the forecast period, leading to steady growth of the myasthenia gravis disease market.

Europe holds the second largest share in the global myasthenia gravis disease market and is likely to remain a leading contender in the global market over the forecast period due to the growing awareness about neuromuscular conditions. Myasthenia gravis holds a significant position in the Europe market, as the disease can cause a significant burden on national healthcare systems. The increasing financial burden of myasthenia gravis disease is likely to drive the myasthenia gravis disease market in Europe over the forecast period.

Asia Pacific is likely to be a major regional market for myasthenia gravis disease over the forecast period due to the growing awareness about the disease and the increasing desire to eliminate the disease from urban populations in growing economies such as China, India, Japan, and South Korea. Increasing healthcare expenditure in the region is likely to be a major driver for the myasthenia gravis disease market over the forecast period. Rising awareness about neuromuscular diseases is likely to be a key driver for the myasthenia gravis disease market in Asia Pacific over the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Amblyopia Market Global Demand, Opportunities, Top Key Players and Forecast to 2030

Amblyopia Market

The amblyopia market is expected to gain a market value of USD 6.25 Billion by 2030 at a CAGR of 4.2% from 2022-2030.

Market Drivers and Barriers

The escalation in number of ophthalmic disorders cases is observed to surge the global amblyopia market. Amblyopia, generally known as lazy eye, mostly develops in childhood. The lack of awareness regarding the onset of amblyopia often leads to severe complications like blindness, with age. Hence, the growing number of undiagnosed incidences are likely to impel the global amblyopia market growth. Furthermore, this is triggering an urgency in the need for early diagnosis. Consequently, an upsurge in the market growth can be expected due to the availability of advanced ophthalmic diagnostic solutions. The market can also experience an amplified growth over the assessment period owing to the hike in per capita income and increase in medical assistance from the government.

The high cost of treatment due to limited treatment options can constraint the amblyopia market growth, despite the presence of such potent market drivers.

Major Key Players:

The major Amblyopia Market Players are McKesson Corporation, Johnson & Johnson, Vivid Vision Inc., Good-Lite Co, Carl Zeiss AG, Amblyotech Inc, Novartis AG., Amblyoptica (Holding) Pvt. Ltd, HOYA Corporation, Krafty Eye Patches¸ Fresnel Prism and Lens Co., Hilco Vision, Cooper Vision, and more.

Segment Analysis

The global amblyopia market has been segmented on the basis of type, treatment, diagnosis, end-user, and region.

By types of amblyopia, the global amblyopia market has been segmented into strabismus amblyopia, reverse amblyopia, deprivation amblyopia, refractive amblyopia, and others. Among these, strabismus amblyopia is the most common type and is mainly caused due to suppression of the misaligned or deviating eye.

By mode of diagnosis, the global amblyopia market has been segmented into photo screening, visual acuity tests, Bruckner test, and others.

By mode of treatment, the global amblyopia market has been segmented into video game, atropine drops, glasses, eye patches, and others. Among these, eye patches hold the largest market share and are anticipated to expand at 3.93 % CAGR during the assessment period.

By mode of end-users, the global amblyopia market has been segmented into ophthalmic clinics, hospitals & pharmacies, and others.

Regional Analysis

Geographically, the amblyopia market span across regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.

Among all the regions, America accounts for the largest market share owing to increasing prevalence of ophthalmological disorders such as macular degeneration, cataract, and glaucoma, growth in technological advancements, presence of key market players, and high expenditure on healthcare.

Europe is considered to be the second largest market followed by Asia Pacific which is presumed to expand at the fastest rate with 4.35 % CAGR during the assessment period. The growth is attributed to the continuously growing economies, rapid technological development, presence of huge patient population, and high opportunity for development in this region.

On the other hand, the Middle East and Africa are considered to register a sluggish growth rate and account for the least market share during the review period owing to low income among the population.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Surgical Lights Market Players, Share, Size, Trend, SWOT Analysis and Forecast to 2030

Surgical Lights Market

As per surgical lights market analysts, the global market is anticipated to witness growth owing to the factors such as high adoption of LED technology in medical lighting as well as advancement in hospital operating rooms. However, the surgical lights market will face challenges and restraints due to increasing number of product recalls and quality issues during the forecast period.

Surgical Lights Market is anticipated to convey its growth with a 4.70% CAGR to influence USD 2.8 Billion by 2030.

The rise in OT facilities around the world in the surgical lights market will support the growth. As per surgical lights market analysts, the surgical lights market based companies will face certain challenges during the forecast period 2016 to 2025. The surgical lights market research report provides in-depth analysis of the application, type, technology, and end-users segments. The surgical lights market research report presents factors such as restrictions due to quality concerns that could slow down the surgical lights market's growth.

Major Key Players:

Global Surgical Lights Market Players are KONINKLIJKE PHILIPS N.V. (Netherlands), A-dec Inc. (US), CV Medical (US), Herbert Waldmann GmbH & Co. KG (Germany), STERIS plc (Ireland), Hill-Rom Services Inc. (US), Integra LifeSciences Corporation (Israel), S.I.M.E.O.N. Medical GmbH & Co. KG (Germany), Getinge AB (Sweden), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Skytron, LLC (US), Stryker (US), Technomed India (India), Sunnex Group (Sweden), and BihlerMED (US),

Segment Analysis

The surgical lights industry has been segmented into application, type, technology, and end-users. Based on the segment which is type, the market is categorized on the basis of surgical lights (mobile surgical lights, surgical headlights, wall mounted, ceiling mounted), examination lights (endoscope light vein light, general exam light, medical pen light). The global market for surgical lights is further segmented based on technology into light emitting diode, halogen light. Furthermore, the market, on the basis of application is segmented into dental procedures, endoscopy procedures, surgical suites, and others. Based on the segment which is end-users, the market is categorized on the basis of ambulatory surgical centers, hospital operating rooms, and procedure rooms.

The market for surgical lights report offers comprehensive study of the surgical lights market segments including application, type, technology, and end-users. The analysts have also studied the surgical lights market's spread across the regional markets across many of the surgical lights market’s segments at country levels. The application, type, technology, and end-users segments spread across the surgical lights industry along with the subsegments are studied. The global market for surgical lights is spread across various product and service based segments. The global surgical lights market research report highlights these key segments and offers forecasts based on primary and secondary data. The global surgical lights market research report presents key company profiles of organizations active across the surgical lights market.

Regional Analysis

The rise in instances of product malfunctions may hinder the surgical lights market growth. The surgical lights market research report suggests that companies in the surgical lights could be supported by the growing number of surgeries carried out on a typical day as well as the advancement in medical technology during the forecast period. The surgical lights market is set to register growth at a high CAGR owing to these key factors. The surgical lights market is spread across North America, Europe, Asia-Pacific, and other parts of the world. As per surgical lights market analysts, the surgical lights market is set to witness tremendous growth across application, type, technology, and end-users segments. The global surgical lights market’s North American region covers surgical lights markets across the United States, Mexico, Canada, and others. Businesses present in the surgical lights market are also profiled and their strategies have been presented in detail in the surgical lights market research report.

The surgical lights industry across the European region covers Italy, France, Germany, and the United Kingdom. Furthermore, the surgical lights market research report provides details about the APAC region covering surgical lights markets from China, India, Australia, Japan, and others. The surgical lights market is also active across several other parts of the world. The surgical lights market report covers all these key regions including the Middle East, Africa, Brazil, and others active in the global surgical lights market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Bone Metastasis Market Players, Demand, Growth, Analysis and Forecast to 2030

 Bone Metastasis Market

The increasing prevalence of breast cancer, growing geriatric population, rising healthcare expenditures, and increasing R&D expenses by the key players are estimated to drive the market growth during the forecast period.

The Bone Metastasis Market is expected to reach USD 17.34 Billion by 2030 at 9.30% CAGR during the forecast period 2022-2030

Bone metastasis is a condition that occurs when cancerous cells from a non-bone site travel, i.e. metastasize, to bones. The spine, particularly the lower spine, the pelvis, and the thighs, are the most common sites for bone metastases. Bone metastasis can cause urinary and bowel incontinence, due to it being located quite close to both the urinary bladder and the rectal column, as well as hypercalcemia. While all cancers can manifest in this way, breast and prostate cancers are the likeliest sources of bone metastasis – 65-75% of patients suffering from breast or prostate cancers experience bone metastasis. The bone metastasis is not often targeted as a separate physiological condition, with the treatment of the original cancer remaining the top priority despite the metastasis. The pain resulting from bone metastases can, however, be combated with pain medication such as narcotics.

The rising geriatric population and the increasing prevalence of breast and prostate cancers is likely to be the major driver for the global bone metastasis market over the forecast period. The growing cultural awareness about breast and prostate cancer, thanks to the two being gender-exclusive diseases that can be marketed as such, is likely to remain a major driver for the global bone metastasis market, as breast and prostate cancers are among the most researched types of cancer in the world. The increasing healthcare expenditure, especially in developing economies, and high amount of efforts in R&D are also likely to drive the bone metastasis market over the forecast period.

On the other hand, the high costs of bone metastasis treatments and the lack of advanced healthcare facilities in emerging regions are likely to restrain the growth of the bone metastasis market in the coming years. The side effects related to bone metastasis treatment could also hamper the global bone metastasis market’s growth over the forecast period.

Major Key Players:

The Bone Metastasis Market Players are F. Hoffmann-La Roche Ltd (Switzerland)

Bayer AG (Germany), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Pharmalucence Inc. (England), Koninklijke Philips N.V. (the Netherlands), GENERAL ELECTRIC (U.S.), Siemens AG (Germany), TOSHIBA CORPORATION (Japan), and others.

Segment Analysis

The global bone metastasis market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into osteolytic bone metastasis, osteoblastic bone metastasis, mixed bone metastasis, and others. On the basis of diagnosis, the market is categorized into biopsy, blood test, imaging, and others. The imaging segment is sub-segmented into X-ray, bone scintigraphy, computerized tomography, magnetic resonance imaging, positron emission tomography, and others. On the basis of treatment, the market is segmented into medical therapies, surgery, medication, and others. The medical therapies segment is sub-segmented into chemotherapy market, targeted therapy, hormone therapy, ablation therapy, and others. The surgery segment is sub-segmented into vertebroplasty, kyphoplasty, and others. The medication segment is sub-segmented into pain medications, bone building medications, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, pharmacies, and ambulatory surgical centers.

Regional Analysis

The Americas is the leading contributor to the global bone metastasis market due to the high healthcare expenditure in developed countries such as Canada and the U.S. and the presence of an advanced healthcare sector that can handle complications related to cancer with relative ease. In the U.S., more than 300,000 new cases of invasive and non-invasive breast cancer are expected to be registered in 2018, while about 1 in 9 men is expected to be diagnosed with prostate cancer over their lifetime. This is likely to drive the demand from the bone metastasis market over the forecast period.

Europe is expected to remain the second largest regional segment of the bone metastasis market due to the consistent technological advancement in the healthcare sector and the increasing willingness of patients to spend more on effective cancer treatment.

Asia Pacific is likely to exhibit the highest growth in the global bone metastasis market over the forecast period due to the growing prevalence of cancer, whereas the Middle East and Africa market is likely to be dominated by the Middle East due to the lack of advanced healthcare facilities in most African countries.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Digital Clinical Workspaces Market Synopsis, Surge, Future Scope, Analysis and Forecast to 2030

Digital Clinical Workspaces Market

Digital Clinical Workspaces Market is expected to reach USD 54.22 Billion by 2030, registering a CAGR of 6.10% during the forecast period.

Healthcare organizations become flexible and high-performing and deliver improved patient outcomes and performance by achieving stable clinical agility. Ensuring security and obtaining and maintaining compliance is now getting easier. By simplifying clinician workflows, reducing IT overhead, and maintaining data security, well outside the walls of the hospital, the right technology makes acceleration possible. The advancement of healthcare IT, the growing use of Electronic Health Record ( EHR) systems, and the increasing focus on the protection of medical records by patients push the growth of the industry. However, during the forecast era, the high cost of digital workspace software solutions available on the market is expected to limit the market 's growth.

Factors such as rising demand for healthcare IT services, development of robust digitized healthcare platforms and increased R&D programs are supporting the market growth. Efforts are also being made to reduce cost of the workspace services.

Major Key Players:

Some of the Digital Clinical Workspaces Market Players are Citrix., System C, VMWare, Inc., Imprivata, Inc., Healthcare at Home, CSC Scandihealth A/S, Kyoto Technologies., Dimension Systems, Inc., and others.

Segment Analysis

The global digital clinical workspaces market is segmented on the basis of component, application, and end-user.

On the basis of component, the market is segmented into security and compliance tools, mobile device management software, identity management software, digital clinic management system and others.

On the basis of application, the market is segmented into medicines administration, e-prescribing, clinical noting, clinical collaboration, and others.

On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, and others.

Regional Analysis

Regions discussed in MRFR’s report include Asia Pacific (APAC), North America, the Middle East & Africa (MEA), South America and Europe. Of these regions, North America accounts for the most impressive market share in terms of revenue. The market growth in North America is primarily attributed to the growing application of healthcare software and digital workspaces to ramp up workflow management. Moreover, growth userbase of e-medical prescription and online consultation services is also creating market opportunities. Many of healthcare technology companies in America offer a wide range of digital workspace services to healthcare professionals such as physicians, doctors, nurse and etc. A considerable number of American physicians use such services for better patient management. Also, strong smartphone penetration is supporting a faster adoption rate.

A greater emphasis is being placed on patient information management coupled with the boom in healthcare IT in America is paving way for advanced healthcare technologies. The healthcare IT sector in South America is also witnessing a fast growth, which remains a positive indicator for market players operating in the region.

In Europe, digital clinical workspace has become somewhat popular well before time. Early adoption and infrastructure support continue to reflect favorably on the market. In terms of revenue, Germany, France, the U.K. are among the key contributors of Europe digital clinical workspaces market. Key factor propelling the Europe market forward are rising importance of delivering quality healthcare service. Rapid digitization in healthcare and growing usage of healthcare software by clinics, hospital and diagnostics centers is are other factors supporting the market growth.

The ongoing economic boom in APAC is drawing tremendous interest towards the region. Realizing the growth potential, many market players are actively expanding operation in the region. Demand for healthcare management services are on the rise in countries such as India and China. Moreover, presence of massive healthcare IT sector further boost the market prospects in the region.

In MEA, the market is expected to demonstrate a steady growth with GCC countries such as UAE and Saudi Arabia making the most amount of contribution. Efforts to raise the standard of healthcare and increased focus on economic diversification are the two main elements for the market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Heart Rate Monitor Market Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2030

Heart Rate Monitor Market

Heart Rate Monitor Market is expected to register a CAGR of 5.20% with USD 12,320 Million by 2030

Wearable medical devices have now gained popularity from last few years owing to their increasing use among the health-conscious people and technological penetration in various regions across the globe. Heart rate monitors are of two types namely, wearable and non-wearable devices. Chest strap, wrist strap, and strapless devices are wearable heart rate monitors. These devices have an embedded sensor which continuously keeps a check on the heart rate of a person during various physical activities as well as when the body is at rest. Key players in the market are tapping new regions in the developing economies across the globe to take a hold of the markets. The global heart rate monitors market is driven by increasing prevalence of cardiovascular diseases and diabetes, rapidly developing technology, and increasing geriatric population across the globe, which has fueled the growth of the market.

According to the World Health Organization, diabetes is a major risk factor for cardiovascular diseases whose prevalence is found to be increased tremendously across the globe. The WHO stated that 422 million people across the globe are suffering from diabetes. The high cost of wearable heart rate devices may restrain the growth of the market over the assessment period. 

Major Key Players:

Some of Key Heart Rate Monitor Market Players are Apple (U.S.), Garmin Ltd.(U.S.), Visiomed Group (France), SAMSUNG ELECTRONICS Co. Ltd. (South Korea), Nike (U.S.), Fitbit Inc. (U.S.), Mio Global (South Korea), Beurer GmbH (Germany), Omron Healthcare (Japan), Inc., LG Electronics (South Korea), nu-beca & maxcellent co. (Taiwan),  Motorola, Polar Electro (Finland), TomTom International BV (The Netherlands), Motorola Solutions, Inc. (U.S.), Sony (Japan), and others. Other players are SUUNTO (Finland), MYZONE (U.S.), Wahoo Fitness (U.S.), Moov Inc. (U.S.), Nokia (Finland), Bragi (Germany), Jabra (Germany), Decathlon (France), and Scosche Industries. (U.S.)

Segment Analysis

The global heart rate monitors market has been segmented on the basis of types, application, and end users. On the basis of the types, the global heart rate monitors market is segmented into wearable and non-wearable devices. The wearable devices are sub-segmented into chest strap, wrist strap, implanted heart monitor and strapless. Non-wearable devices are sub-segmented into analog and digital. Based on the application, it is segmented into sports, medical, and others. On the basis of the end users, the market is segmented into hospital & clinics, sport medicine centers, professionals, individuals, and others.

Regional Analysis

In the Americas, the market exhibits tremendous growth owing to an extensive use of heart rate monitors by the people and healthcare providers in hospitals and clinics. The U.S. is the largest market in the Americas owing to increasing patient population suffering from chronic diseases such as cardiovascular diseases and diabetes. The key players are engaged in product differentiation and geographical expansion to maintain their position in the market.

Europe is the second largest market followed by Asia Pacific. In Europe, the market shows growth opportunities in Germany, the U.K, and France. This growth is due to increasing availability of funds for research and development activities and rising prevalence of diabetes. Strong government support and high healthcare expenditure are driving the growth of the market.

Asia Pacific is the fastest growing market owing to increasing prevalence of diabetes and obesity and high geriatric population in developing regions such as India, China, and Japan, Additionally, increasing demand for technologically advanced wearable medical devices such as smartwatches and chest strap is further boosting the market growth. Moreover, increasing government support and presence of huge opportunity in medical device industry have together fueled the growth of the market in Asia Pacific region.

In the Middle East & Africa, the market exhibits steady growth owing to an increasing demand for healthcare services and positive growth of healthcare industry. The Middle East & African market is governed by increasing availability of tertiary healthcare services and growing awareness about cardiovascular diseases. In Africa, the market shows steady growth due to the limited availability of medical facilities, demand for primary care services, and poor economic condition in the African countries.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com